Loading provider…
Loading provider…
Dermatology Physician in Columbus, OH
NPI: 1073833042Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get MD Benjamin's Phone NumberMobile
Get MD Benjamin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License

American Board of Dermatology
Dermatology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 234 | 325 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 136 | 206 |
| 3 | 17000Destruction of skin growth | 104 | 125 |
| 4 | 17003Destruction of 2-14 skin growths | 71 | 310 |
| 5 | 99451Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review | 68 | 68 |
Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.
Authors: Brady Evans, Brittany Dulmage
Journal: Drugs R D
Vancomycin-associated DRESS demonstrates delay in AST abnormalities.
Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series.
Authors: Jennifer Sopkovich, Lucia Seminario Vidal
Journal: Int J Dermatol
Publication Date: 2021-03-04
Lead Sponsor: OnQuality Pharmaceuticals (USA) LLC
Intervention / Treatment: DRUG: Vehicle Ointment, DRUG: OQL011
Lead Sponsor: Ohio State University
Collaborators: Eli Lilly and Company
Intervention / Treatment: BIOLOGICAL: Ixekizumab